Lauren Santye, Assistant Editor

New research may transform oncology drug development.

Researchers warn political interference may discourage shared decision-making in breast cancer treatment.

Use of exomes shield lung cancer drug from immune system defenses.

HCV treatment has been shown to cure up to 100% of patients depending on genotype and stage of liver disease.

Global therapeutics market for chronic hepatitis B virus projected to rise from $2.4 billion to $3 billion by 2024.

Venetoclax is a B-cell lymphoma-2 protein inhibitor for the treatment of CLL patients who received a least one prior therapy.

A young Navy veteran finds hope in his struggle with amyotrophic lateral sclerosis, as the hunt for a cure continues.

Researchers examine use of docetaxel in patients with castration-resistant metastatic prostate cancer following androgen-deprivation therapy.

Byproduct found in cotton plant rid the body of abnormal cancerous cells.

Merck required to pay $830 million in damage recovery related to discontinued arthritis drug.

Researchers examine use of docetaxel in patients with castration-resistant metastatic prostate cancer following androgen-deprivation therapy.

Use of exomes shield lung cancer drug from immune system defenses.

Researchers examine how genetic changes in breast cancer cells interfere with pathways critical to disease growth and survival.

Study seeks to address underpayments received by low-income Medicare beneficiaries or dual eligibles.

Research examines accuracy of health care information on discussion board web sites Reddit, Mumsnet, and Patient.

Arzerra found to nearly double progression-free survival in chronic lymphocytic leukemia compared with observation.

Arzerra found to nearly double progression-free survival in chronic lymphocytic leukemia compared with observation.

Metformin decreased inflammation and scarring observed in more common pancreatic cancers.

Combination of diclofenac with chemotherapy and radiation may greatly improve treatment of cancer patients.

Combination of diclofenac with chemotherapy and radiation may greatly improve treatment of cancer patients.

Pomalyst was approved in 2013 for use in combination with dexamethasone to inhibit tumor growth.

Controversial proposal would essentially do away with copayments and deductibles.

Cosentyx was previously approved for the treatment of moderate-to-severe plaque psoriasis.

Controversial proposal would essentially replace health care plans Americans currently obtain via their employers or purchased individually.

Few state minor-consent laws authorize participation in clinical trials and therapies.

Cosentyx was previously approved for the treatment of moderate-to-severe plaque psoriasis.

Study seeks to address underpayments received by low-income Medicare beneficiaries or dual eligibles.

Research examines long non-coding RNAs as biomarkers and therapeutic targets.

PKN proteins are gaining recognition as drug targets for cancer research.

Government announces plans to increase funding for cancer treatment research and development.